Australia is Gavi’s largest donor and strongest supporter in Asia. In addition, Australian’s contribution to immunology, virology, vaccine development and global public health, combined with their successful domestic immunisation record demonstrates the government’s strong commitment to immunisation. As such, the country has taken a leadership role in the region and beyond.
Australia has been a donor to Gavi since 2006 and contributes to the Alliance through both direct contributions and IFFIm.
Between 2006 and 2010, Australia’s total direct contribution to Gavi was AUD 34 million. For the 2011-2015 period, Australia contributed a total of AUD 250 million in direct contributions. Australia’s IFFIm contribution of AUD 250 million over 20 years was signed in March 2011.
At the Berlin Pledging Conference 2015, Australia announced a five-year commitment of AUD 250 million which covers the complete cycle of the next period of 2016-2020. Australia continues to support IFFIm and directed 15% of the new pledge to IFFIm.
Recognizing Gavi’s impact in the Indo-Pacific region and considering Gavi’s continued contribution to access to vaccines for countries in the region, Australia pledged AUD 300 million at the 2020 Global Vaccine Summit. On 26 August 2020, Australia further pledged AUD 80 million to AMC to improve access for low-resourced countries including those from the Pacific and Southeast Asian region to safe, effective, and affordable COVID-19 vaccines.
Contributions and pledges in total:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2019 and Q1-Q3 2020 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2019 and Q1-Q3 2020 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020.
Future contributions (for pledges at the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020 and years
Future contributions: non-US$ contributions for Q4-2020 and for years 2021 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 September 2020
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2020, IFFIm donor grant payments are reduced by 0.5%, however such reductions are not reflected in future contributions figures.